1. Home
  2. ASTH vs CMPX Comparison

ASTH vs CMPX Comparison

Compare ASTH & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$24.79

Market Cap

996.1M

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.50

Market Cap

926.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
CMPX
Founded
1994
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
996.1M
926.7M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
ASTH
CMPX
Price
$24.79
$5.50
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
$35.33
$14.43
AVG Volume (30 Days)
571.8K
1.8M
Earning Date
06-04-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.33
N/A
Revenue
$519,907,752.00
N/A
Revenue This Year
$26.88
N/A
Revenue Next Year
$10.78
N/A
P/E Ratio
$75.91
N/A
Revenue Growth
45.90
N/A
52 Week Low
$18.08
$1.33
52 Week High
$34.80
$6.88

Technical Indicators

Market Signals
Indicator
ASTH
CMPX
Relative Strength Index (RSI) 58.63 38.69
Support Level $23.37 $4.78
Resistance Level $28.49 $5.86
Average True Range (ATR) 1.35 0.32
MACD 0.82 -0.10
Stochastic Oscillator 76.37 17.18

Price Performance

Historical Comparison
ASTH
CMPX

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: